Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Sales: 2019-2024

Historic Return on Sales for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to 1.05%.

  • Silence Therapeutics' Return on Sales fell 10808.00% to 131.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.50%, marking a year-over-year increase of 204.00%. This contributed to the annual value of 1.05% for FY2024, which is 67.00% up from last year.
  • Latest data reveals that Silence Therapeutics reported Return on Sales of 1.05% as of FY2024, which was up 38.88% from 1.71% recorded in FY2023.
  • In the past 5 years, Silence Therapeutics' Return on Sales registered a high of 1.05% during FY2024, and its lowest value of 5.94% during FY2020.
  • Moreover, its 3-year median value for Return on Sales was 1.71% (2023), whereas its average is 1.83%.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 7,431bps in 2020, then plummeted by 44bps in 2022.
  • Over the past 5 years, Silence Therapeutics' Return on Sales (MRY) stood at 5.94% in 2020, then skyrocketed by 47bps to 3.17% in 2021, then grew by 14bps to 2.74% in 2022, then soared by 37bps to 1.71% in 2023, then soared by 39bps to 1.05% in 2024.
  • Its last three reported values are 1.05% in FY2024, 1.71% for FY2023, and 2.74% during FY2022.